CHRONOTHERAPY OF NOCTURNAL ASTHMA AND RECENT PATENTS: A REVIEW
Journal Title: Journal of Biomedical and Pharmaceutical Research - Year 2017, Vol 6, Issue 3
Abstract
The study of biological rhythms is called chronobiology. Many diseases have been found to show rhythm in their symptoms and severity. To treat such diseases the timing of drug administration is matched with circadian rhythms of the disease and such treatment is called chronotherapy. Asthma is one of the many diseases showing rhythmicity in its symptoms. Night time worsening of asthma has been reported in literature from early times. For the effective management of asthma patient needs to take medicine so that effective concentration of the drug is maintained throughout the night especially during early morning hours.Chronotherapy of asthma has been done using various drugs which include β2-adrenergic agonist medication such as short acting β2-adrenergic agonist (SABA) and long acting β2-adrenergic agonist (LABA). Terbutaline sustained release tablet formulation was one of the first to be assessed in chronotherapy trials. Other drugs to be studied for chronotherapy are theophylline, prednisolone (Systemic corticosteroids), Tiotropium (anticholinergic agent), Montelukast, Pranlukast, and Zafirlukast (leukotriene receptor antagonists). Chronotherapy of nocturnal asthma has shown promising results but right dosing and timing is necessary to yield such results. Chronotherapeutic drug delivery systems are formulated to achieve the right time delivery of the drugs to match biological rhythms of the disease. Different formulation strategies are followed to achieve such delivery. Present review outlines the basics of chronotherapy along with chronotherapy of Nocturnal asthma and patents granted for chronotherapeutic drug delivery systems for asthma.
Authors and Affiliations
Prabhjot Singh Bajwa*| Ch. Devilal College of Pharmacy, Jagadhri, Yamunanagar, Haryana, India., Jaya Sharma| School of Pharmaceutical Sciences, Jaipur National University, Jaipur, Rajasthan, India, Anurag Bhargava| Ch. Devilal College of Pharmacy, Jagadhri, Yamunanagar, Haryana, India., Shailesh Sharma| Department of pharmaceutics, Amar Shaheed Baba Ajit Singh Jujhar Singh Memorial College of Pharmacy, Bela, Ropar, Punjab, India., Abhimanyu Rai Sharma| Ch. Devilal College of Pharmacy, Jagadhri, Yamunanagar, Haryana, India., Binu Sharma| Ch. Devilal College of Pharmacy, Jagadhri, Yamunanagar, Haryana, India.
Keywords
Related Articles
- EP ID EP3848
- DOI -
- Views 480
- Downloads 23
COMPARITIVE EVALUATION OF TISSUE GLYCOGEN AND SALIVARY PH IN CHRONIC GINGIVITIS AND CHRONIC PERIODONTITIS PATIENTS
BACKGROUND: The inflammation of gingiva is known as gingivitis with microorganisms present in the gingival sulcus, being the major cause for this pathologic condition. Periodontitis is a chronic inflammatory disease whic...
ISOLATION AND EVALUATION OF DISINTEGRATING PROPERTIES OF BASELLA ALBA Linn. LEAF MUCILAGE IN TABLET FORMULATIONS
There are number of synthetic polymers are available in market for pharmaceutical formulations, but these synthetic polymers have certain disadvantages such as high cost, toxicity, environmental pollution during synthesi...
PRELIMINARY CHARACTERIZATION, ANTIOXIDANT ACTIVITIES AND ULCER CURATIVE EFFECT OF OPUNTIA FICUS INDICA F. INERMIS ROOTS POLYSACCHARIDES IN RATS
The present study was undertaken to investigate the in vitro antioxidant activity and the in vivo curative effect of Opuntia ficus indica f. inermis polysaccharides (OFIP) against ethanol- induced ulcer in rats. Accordi...
TOXICITY OF KHAYA GRANDIFOLIOLA (AFRICAN MAHOGANY) BARK WATER EXTRACT AGANIST BIOMOPHLARIA SNAILS
Background: Molluscicides are crucial for the control of schistosomiasis and other snail-borne infections. The need to use plant s has received increased interest as an inexpensive technology because of the high cost of...
NAD (P) H: QUINONE OXIDOREDUCTASE 1(NQO1) POLYMORPHISMIN SUDANESE PATIENTS WITH ESSENTIAL THROMBOCYTHAEMIA
Primary or essential thrombocythaemia (ET) is a clonal haemopoietic disorder, it is one of myeloproliferative neoplasm (MPN)that manifests primarily as a marked increase in platelets count with spontaneous aggregation of...